Auckland, New Zealand

Jack Urquhart Flanagan

This inventor holds 6 USPTO granted patents and 3 EPO patents. Top assignees: Auckland Uniservices Limited, Vetdc, Inc., Pathway Therapeutics Inc.. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jack Urquhart Flanagan. Retrieved from https://idiyas.com/inventor/jack-urquhart-flanagan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Jack Urquhart Flanagan: Pioneering Innovations in Biochemical Patents**

Introduction

Jack Urquhart Flanagan, based in Auckland, New Zealand, is a distinguished inventor with a remarkable portfolio of six patents. His innovative contributions primarily focus on advancements in biochemical research and applications, shaping methodologies for treating various diseases.

Latest Patents

Among Flanagan's latest patents, two stand out for their significant impact on medical science. The first patent involves **tricyclic heterocyclic derivatives and uses thereof**, which disclose compounds exhibiting kinase inhibitory activity. These compounds are particularly beneficial in treating diseases mediated by CSF-1R (c-FMS kinase), including proliferative and neoplastic diseases like cancers, as well as bone, inflammatory, and autoimmune conditions.

The second notable patent, related to **bacterial nitroreductase enzymes and methods relating thereto**, outlines the functional use of these enzymes in non-invasive imaging techniques, monitoring of therapeutic cell populations, and gene-directed enzyme prodrug therapy. This invention also highlights applications in radioimaging and ablation of biological agents, showcasing Flanagan's ability to push the boundaries of biochemistry.

Career Highlights

Jack Urquhart Flanagan has collaborated with notable organizations, including VetDC, Inc. and Auckland Uniservices Limited. His work with these companies has facilitated the transition of scientific research into practical applications, enhancing the medical field's capacity to treat complex diseases.

Collaborations

Throughout his career, Flanagan has collaborated with talented professionals, including Gordon William Rewcastle and Swarnalatha Akuratiya Gamage. These collaborations reflect a collective effort to innovate and advance biomedical research, ultimately leading to potential breakthroughs in healthcare.

Conclusion

Jack Urquhart Flanagan exemplifies an innovative spirit in the field of biochemical research through his patents and collaborations. His work continues to contribute to the medical community's efforts in tackling diseases, demonstrating the essential role of inventors in advancing technology and healthcare. His ongoing research promises to uncover further applications and solutions for various medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…